By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Nabriva Therapeutics 

Leberstrasse 20

Vienna    1112  Austria
Phone: 43-0-1-74093-0 Fax: 43-0-1-74093-1900


Company News
Nabriva Provides Development Update And Reports Nine Month 2015 Financial Results 11/11/2015 8:45:03 AM
Nabriva To Provide Development Update And Announce Nine Month 2015 Financial Results; Conference Call On Wednesday, November 11, 2015 11/4/2015 8:23:27 AM
Nabriva Hires Will Sargent As Vice President Of Commercial Strategy And Investor Relations 10/14/2015 12:01:48 PM
Nabriva Presents Data On Lefamulin At The 2015 ID Week In San Diego 10/13/2015 12:45:28 PM
Nabriva Announces Closing Of Its Initial Public Offering 9/24/2015 10:27:49 AM
Should You Invest in Nabriva IPO? 9/18/2015 8:03:28 AM
Nabriva, REGENXBIO, and Penumbra Set to Go Public This Week 9/14/2015 9:27:08 AM
Nabriva Appoints Elyse Seltzer MD As Chief Medical Officer 5/21/2015 9:15:34 AM
Nabriva Presents Data On Extended Spectrum Pleuromutilin Antibiotics At The 25th European Congress Of Clinical Microbiology And Infectious Diseases, Copenhagen 4/24/2015 1:25:06 PM
Nabriva Raises $120 Million, Headed to Phase III for New Antibiotic 4/7/2015 5:50:04 AM